FDA Inspection
Pharmaceutics International IncPharmaceutics International Inc – FDA Inspection, May 22, 2013
Record Details
This FDA Inspection record concerns Pharmaceutics International Inc, with an inspection on May 22, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 22, 2013
- Product Type
- Drugs
View Company Profile
ID · 14d9b29d-84bd-4271-a327-a2096b85cef9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 832603
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Pharmaceutics International Inc
13| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2024 | VAI | Baltimore District Office | Drug Quality Assurance |
| November 14, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2018 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Pharmaceutics International Inc
- FDA Inspection 1251950 - 2024-12-06
- FDA Inspection 1194130 - 2022-11-14
- FDA Inspection 1155001 - 2021-09-29
- FDA Inspection 1124614 - 2020-07-10
- FDA Inspection 1071297 - 2018-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.